T
Originally published by The Standardtop
February 26, 2026
11h ago
Doctors back twice-yearly HIV jab, warn it won't work for everyone
Doctors have backed a new injectable drug for HIV prevention, even as they raised a red flag over the sustainability of a rollout...
✨ Key Highlights
Kenyan doctors have backed the new twice-yearly injectable HIV prevention drug, Lenacapavir, during its official launch in Nairobi, while raising concerns about long-term funding sustainability.
- Kenya Medical Association (KMA) supports Lenacapavir as a new HIV prevention method.
- The drug is administered twice a year and is the first of its kind in East Africa.
- Doctors advise caution regarding potential drug interactions and recommend screening for STIs and hepatitis, especially for individuals with hepatitis B.
- The rollout targets key populations most at risk and is currently heavily reliant on donor funding.
Continue Reading
Read the complete article from The Standard
Advertisement
Advertisement